www.fdanews.com/articles/122796-genzyme-blood-cancer-treatment-shows-promise
Genzyme Blood Cancer Treatment Shows Promise
December 8, 2009
Genzyme Corp., a Cambridge biotechnology company, said it is encouraged by early test results
of its drug Mozobil as part of a potential strategy to attack blood cancers.
The Boston Globe
The Boston Globe